Recently, Zeng and collaborators conducted a comprehensive review highlighting the crucial role of MDM2 in shaping the immune microenvironment, facilitating tumor immune evasion, and driving hyperprogression during immunotherapy. This evidence concerns the gene MDM2 and neoplasm.